SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
View HTML
SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
View HTML
SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
View HTML
SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
View HTML
SC TO-C

Written public communication relating to an issuer or third party tender offer

Mergers & Acquisitions
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
RW

Withdrawal of registration statement filed under the Securities Act

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML
UPLOAD

UPLOAD

Other
View HTML

Data provided by Kaleidoscope.